GruntzigARSenningASiegenthalerWE. Nonoperative dilatation of coronary-artery stenosis: Percutaneous transluminal coronary angioplasty. N Engl J Med.1979; 301: 61–68.
2.
SerruysPWde JaegerePKiemeneijF. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med.1994; 331: 489–495.
3.
FischmanDLLeonMBBaimDS. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med.1994; 331: 496–501.
4.
LoweHCOesterleSNKhachigianLM. Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol.2002; 39: 183–193.
5.
MoriceMCSerruysPWSousaJE. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med.2002; 346: 1773–1780.
6.
ParkSJShimWHHoDS. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med.2003; 348: 1537–1545.
7.
SchwartzRSChronosNAVirmaniR. Preclinical restenosis models and drug-eluting stents: Still important, still much to learn. J Am Coll Cardiol.2004; 44: 1373–1385.
8.
LangeveldBRoksAJTioRA. Rat abdominal aorta stenting: A new and reliable small animal model for in-stent restenosis. J Vasc Res.2004; 41: 377–386.
9.
LangeveldBvan GilstWHZijlstraF. A simple, inexpensive, rapid and accurate model for in-stent restenosis [Letter]. J Am Coll Cardiol.2005; 45: 1310.
10.
JahnkeTKarbeUSchäferFK. Characterization of a new double-injury restenosis model in the rat aorta. J Endovasc Ther.2005; 12: 318–331.
11.
JahnkeTSchäferFKBolteH. Short-term rapamycin for inhibition of neointima formation after balloon-mediated aortic injury in rats: Is there a window of opportunity for systemic prophylaxis of restenosis?J Endovasc Ther2005; 12: 332–342.
12.
IndolfiCEspositoGStabileE. A new rat model of small vessel stenting. Basic Res Cardiol.2000; 95: 179–185.
13.
FinnAVGoldHKTangA. A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res.2002; 39: 414–425.
14.
LoweHCJamesBKhachigianLM. A novel model of in-stent restenosis: Rat aortic stenting. Heart. 2005; 91: 393–395.
15.
PrattREDzauVJ. Pharmacological strategies to prevent restenosis: Lessons learned from blockade of the renin-angiotensin system. Circulation. 1996; 93: 848–852.
16.
LangeveldBRoksAJTioRA. Renin-angiotensin system intervention to prevent in-stent restenosis: An unclosed chapter. J Cardiovasc Pharmacol.2005; 45: 88–98.
17.
SchwartzRSEdelmanERCarterA. Drug-eluting stents in preclinical studies: Recommended evaluation from a consensus group. Circulation. 2002; 106: 1867–1873.
